MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $29,258,000 | -22.5% | 1,755,099 | -4.3% | 0.00% | -33.3% |
Q3 2016 | $37,761,000 | -32.7% | 1,834,859 | +0.1% | 0.01% | -33.3% |
Q2 2016 | $56,099,000 | -19.7% | 1,833,291 | -1.7% | 0.01% | -25.0% |
Q1 2016 | $69,823,000 | -7.2% | 1,865,430 | +7.0% | 0.01% | 0.0% |
Q4 2015 | $75,278,000 | +20.0% | 1,744,164 | +4.2% | 0.01% | +9.1% |
Q3 2015 | $62,729,000 | +6.6% | 1,673,660 | -3.3% | 0.01% | +22.2% |
Q2 2015 | $58,836,000 | -11.3% | 1,730,967 | -7.6% | 0.01% | -10.0% |
Q1 2015 | $66,309,000 | +1.8% | 1,873,135 | -2.0% | 0.01% | 0.0% |
Q4 2014 | $65,126,000 | -9.4% | 1,912,109 | +2.6% | 0.01% | -16.7% |
Q3 2014 | $71,889,000 | -1.4% | 1,863,855 | -0.5% | 0.01% | 0.0% |
Q2 2014 | $72,875,000 | +13.0% | 1,872,432 | -0.8% | 0.01% | +9.1% |
Q1 2014 | $64,515,000 | +41.9% | 1,886,961 | -13.0% | 0.01% | +37.5% |
Q4 2013 | $45,478,000 | -3.0% | 2,167,690 | +8.7% | 0.01% | -11.1% |
Q3 2013 | $46,884,000 | -16.5% | 1,995,056 | -4.6% | 0.01% | -18.2% |
Q2 2013 | $56,164,000 | – | 2,090,221 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |